Use of combination antiretroviral therapy in Pregrant Women with HIV Disease

MCN The American Journal of Maternal Child Nursing

Volumn 23, Issue 6, 1998, Pages 307-312

  Newshan, Gayle ^a   Hoyt, Mary Jo ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

HIV; Pregnancy; Protease inhibitors

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; CASE REPORT; DISEASE TRANSMISSION; DRUG COMBINATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; VIROLOGY;

ADULT; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0032215262     PISSN: 0361929X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005721-199811000-00006     Document Type: Article

References (22)

1. Bardeguez, A. (1996). Management of HIV infection for the childbearing age woman. Clinical Obstetrics and Gynecology, 39, 344-360.
2. Buyer, P., Dillon, M., Navale, M., Deveikis, A., Keller, M., O'Rourke, S., & Bryson, Y. (1994). Factors predictive of maternal-fetal transmission of HIV-1: Preliminary analysis of zidovudine given during pregnancy and/or delivery. Journal of the American Medical Association, 271, 1925-1930.
3. Bryson, Y., Luzuriaga, K., Sullivan, J., & Wara, D. (1992). Proposed definitions for in utero versus intraparturn transmission of HIV-1. New England Journal of Medicine, 327, 1246-1247.
4. Cao, Y., Krogstad, P., Korber, B., Koup, R., Muldoon, M., Macken, C., Song, J., Jin, Z., Zhao, J., Clapp, S., Chen, I., Ho, D., & Ammann, A. (1997). Maternal HIV-1 viral load and vertical transmission of infection. Nature Medicine, 3, 549-552.
5. Carpenter, C., Fischl, M., Hammer, S., Hirsch, M., Jacobsen, D., Katzenstein, D., Montaner, J., Richman, D., Saag, M., Schooley, R., Thompson, M., Bella, S., Yeni, P., & Volberding, P. (1996). Consensus statement: Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. Journal of the American Medical Association, 276, 146-154.
6. Centers for Disease Control and Prevention. (1994). Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morbidity and Mortality Weekly Report, 43(RR-11), 1-20.
7. Connor, E., Sperling, R., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M., Van Dycke, R., Bey, M., Shearer, W., Jacobson, R., Jiminez, E., O'Neill, E., Bazin, B., Delfraissy, J., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, P., & Balsley, J. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine, 331, 1173-1180.
8. Cooper, E., Nugent, R., Diaz, C., Pitt, J., Hanson, C., Kalish, L., Mendez, H., Zorilla, C., Hershow, R., Moye, J., Smeriglio, V., & Fowler, M. (1996). After AIDS Clinical Trial 076: The Changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. The Journal of Infectious Disease, 174, 1207-1211.
9. Dickover, R., Garratty, E., Herman, S., Myung-Shin, S., Plaeger, S., Boyer, P., Keller, M., Deveikis, A., Stiehm, R., Bryson, Y. (1996). Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Journal of the American Medical Association 275, 599-605.
10. Doran, C. (1997). New approaches to using antiretroviral therapy for the management of HIV infection. The Annals of Pharmacotherapy, 31, 228-236.
11. European Collaborative Study. (1992). Risk factors for mother-child transmission of HIV Lancet, 339, 1007-1012.
12. Levin, J. (1997). FDA receives reports of diabetes-like symptoms. NATAP Reports, A Bulletin from the National AIDS Treatment Advocacy Project, 2, 20.
13. Lindgren, S., Anzen, B., Bohlin, A., & Lidman, K. (1991). HIV and childbearing: Clinical outcome and aspects of mother-to-infant transmission. AIDS, 5, 1111-1116.
14. Matheson, P., Abrams, E., Thomas, P., Hernan, M., Thea, D., Lambert, G., Krasinski, K., Bamji, M., Rogers, M., Heagart, M., & the New York City Perinatal HIV Transmission Colloborative Study Group. (1995). Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The Journal of Injections Diseases, 172, 353-358.
15. Mayaux, M., Dussaix, E., Isopet, J., Rekacewicz, C., Mandelbrot, L., Ciraru-Vigneron, N., Allemon, M., Chambrin, V., Katlama, C., Delfraissy, J., & Puel, J. (1997). Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohort studies. The Journal of Infectious Diseases, 175, 172-175.
16. Minkoff, H., & Augenbraun, M. (1997). Antiretroviral therapy for pregnant women. American Journal of Obstetrics and Gynecology, 176, 478-489.
17. Minkoff, H., Burns, D., Landesman, S., Youchah, J., Goedert, J., Nugent, R., Muenz, L., & Willoughby, A. (1995). The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. American Journal of Obstetrics and Gynecology, 173, 585-589.
18. National Institutes of Health. (1997). Draft of the Report of the NIH Panel to define principles of therapy of HIV infection. Washington, DC.
19. Nibbelink, D. (1998). Efavirenz (DMP266) Safety report. Wilmington, DE: DuPont Merck Research and Development.
20. O'Sullivan, M., Bayer, P., Scott, G., Parks, W., Weller, S., & Blum, M. (1993). The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with HIV and their infants: Phase I ACTG study (protocol 082). American Journal of Obstetrics and Gynecology, 168, 1510-1516.
21. Sperling, R., Shapiro, D., & Coombs, R. (1996). Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus from mother to infant. New England Journal of Medicine, 335, 1621-1629.
22. Van de Perre, P., Simonon, A., Msellati, P., Hiltmana, D., Vaira, D., Bazubagira, A., VanGoethem, C., Stevens, A., Karita, E., & Sondog-Thull, D. (1991). Postnatal transmission of immunodeficiency virus type 1 from mother to infant: A prospective cohort study in Kigali, Rwanda. New England Journal of Medicine, 325, 593-598.